Literature DB >> 23969190

Testicular adrenal rest tumors develop independently of long-term disease control: a longitudinal analysis of 50 adult men with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency.

Nicole Reisch1, Marietta Rottenkolber, Anais Greifenstein, Nils Krone, Heinrich Schmidt, Martin Reincke, Hans-Peter Schwarz, Felix Beuschlein.   

Abstract

CONTEXT: Testicular adrenal rest tumors (TARTs) and hypogonadotropic hypogonadism are the two most common causes for male infertility in classic 21-hydroxylase deficiency. Current hypotheses suggest the quality of disease control to be one of the main pathogenic factors for TART development.
OBJECTIVE: The aim was to study long-term predictors for TART development in a retrospective longitudinal study.
DESIGN: Fifty men with classic 21-hydroxylase deficiency (31 salt wasting, 19 simple virilizing) were investigated. Testicular ultrasound at a median age at investigation of 27 years detected TARTs in 28 of 50 subjects (19 salt wasting, 9 simple virilizing). TART presence was correlated with long-term parameters of disease control during childhood and adolescence obtained from patients' charts: 24-hour urine pregnanetriol, serum 17-hydroxyprogesterone, onset and stage of pubic hair development, testicular growth, and bone age in relation to chronological age.
RESULTS: There was no difference in pregnanetriol excretion over lifetime between patients with and without TARTs. Similarly, neither development of pubic hair and testicular volume (Tanner) nor bone age in relation to chronological age differed between the two groups. Furthermore, the two groups had the same body mass index and the same impairment of final height in relation to midparental target height.
CONCLUSION: Our longitudinal analysis demonstrates no association between TART presence and parameters of disease control. These data, therefore, argue for other mechanisms more relevant for TART induction including those occurring during fetal development.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23969190     DOI: 10.1210/jc.2012-3181

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

Review 1.  Toying with fate: Redirecting the differentiation of adrenocortical progenitor cells into gonadal-like tissue.

Authors:  Theresa Röhrig; Marjut Pihlajoki; Ricarda Ziegler; Rebecca S Cochran; Anja Schrade; Maximiliaan Schillebeeckx; Robi D Mitra; Markku Heikinheimo; David B Wilson
Journal:  Mol Cell Endocrinol       Date:  2014-12-08       Impact factor: 4.102

Review 2.  Adrenal steroidogenesis and congenital adrenal hyperplasia.

Authors:  Adina F Turcu; Richard J Auchus
Journal:  Endocrinol Metab Clin North Am       Date:  2015-06       Impact factor: 4.741

Review 3.  GATA factors in endocrine neoplasia.

Authors:  Marjut Pihlajoki; Anniina Färkkilä; Tea Soini; Markku Heikinheimo; David B Wilson
Journal:  Mol Cell Endocrinol       Date:  2015-05-28       Impact factor: 4.102

Review 4.  Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome.

Authors:  Henrik Falhammar; Anna Nordenström
Journal:  Endocrine       Date:  2015-06-17       Impact factor: 3.633

Review 5.  Congenital Adrenal Hyperplasia.

Authors:  Selma Feldman Witchel
Journal:  J Pediatr Adolesc Gynecol       Date:  2017-04-24       Impact factor: 1.814

6.  Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline.

Authors:  Phyllis W Speiser; Wiebke Arlt; Richard J Auchus; Laurence S Baskin; Gerard S Conway; Deborah P Merke; Heino F L Meyer-Bahlburg; Walter L Miller; M Hassan Murad; Sharon E Oberfield; Perrin C White
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

Review 7.  Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.

Authors:  Hedi L Claahsen-van der Grinten; Phyllis W Speiser; S Faisal Ahmed; Wiebke Arlt; Richard J Auchus; Henrik Falhammar; Christa E Flück; Leonardo Guasti; Angela Huebner; Barbara B M Kortmann; Nils Krone; Deborah P Merke; Walter L Miller; Anna Nordenström; Nicole Reisch; David E Sandberg; Nike M M L Stikkelbroeck; Philippe Touraine; Agustini Utari; Stefan A Wudy; Perrin C White
Journal:  Endocr Rev       Date:  2022-01-12       Impact factor: 19.871

8.  11-Oxygenated Androgens Are Biomarkers of Adrenal Volume and Testicular Adrenal Rest Tumors in 21-Hydroxylase Deficiency.

Authors:  Adina F Turcu; Ashwini Mallappa; Meredith S Elman; Nilo A Avila; Jamie Marko; Hamsini Rao; Alexander Tsodikov; Richard J Auchus; Deborah P Merke
Journal:  J Clin Endocrinol Metab       Date:  2017-08-01       Impact factor: 5.958

9.  Testicular adrenal rest tumors in boys with 21-hydroxylase deficiency, timely diagnosis and follow-up.

Authors:  Mirjana Kocova; Vesna Janevska; Violeta Anastasovska
Journal:  Endocr Connect       Date:  2018-03-12       Impact factor: 3.335

Review 10.  Treatment and health outcomes in adults with congenital adrenal hyperplasia.

Authors:  Thang S Han; Brian R Walker; Wiebke Arlt; Richard J Ross
Journal:  Nat Rev Endocrinol       Date:  2013-12-17       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.